Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evidence that circulating immune complexes remove transfused platelets from the circulation

J Kutti, C G Zaroulis, S Safai-Kutti

    American Journal of Hematology
    |November 1, 1981
    PubMed
    Summary

    Circulating immune complexes (CIC) can reduce the effectiveness of prophylactic platelet transfusions in acute leukemia patients. Elevated CIC levels before transfusion correlate with lower post-transfusion platelet counts, impacting treatment benefits.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Some storage characteristics of platelet concentrates contaminated with pseudomonas aeruginosa.

    Platelets·2010
    Same author

    Identification of a novel allele HLA-DQB1*0622.

    Tissue antigens·2007
    Same author

    Characterization of a novel allele HLA-B*3549.

    Tissue antigens·2005
    Same author

    Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Göteborg, Sweden, during 1983-99.

    Journal of internal medicine·2004
    Same author

    The incidence and survival of acute de novo leukaemias in Estonia and in a well-defined region of western Sweden during 1982-1996: a survey of patients aged > or =65 years.

    Journal of internal medicine·2004
    Same author

    Negligible clinical effects of thalidomide in patients with myelofibrosis with myeloid metaplasia.

    Medical oncology (Northwood, London, England)·2002

    Area of Science:

    • Hematology
    • Immunology
    • Oncology

    Background:

    • Acute leukemias require intensive chemotherapy, often leading to thrombocytopenia.
    • Thrombocytopenia necessitates prophylactic platelet transfusions to prevent bleeding.
    • The efficacy of platelet transfusions can be influenced by patient-specific factors.

    Purpose of the Study:

    • To investigate the impact of circulating immune complexes (CIC) on the effectiveness of prophylactic platelet transfusions in acute leukemia patients.
    • To determine if pre-transfusion CIC levels correlate with post-transfusion platelet increments.

    Main Methods:

    • Study included 15 newly diagnosed acute leukemia patients undergoing induction chemotherapy.
    • 67 prophylactic platelet transfusion therapies were administered to thrombocytopenic patients (platelet count < 20 X 10(9)/l).

    Related Experiment Videos

  • Serum CIC concentrations were measured using Raji cell radioimmunoassay immediately before and 10-12 hours after each transfusion.

    • Main Results:

    • Elevated CIC levels were detected in 36 of 67 pre-transfusion samples.
    • Post-transfusion CIC levels were significantly lower (P < 0.05) in instances with elevated pre-transfusion CIC.
    • Patients with elevated pre-transfusion CIC showed significantly lower post-transfusion platelet increments (P < 0.001) compared to those with normal CIC levels.

    Conclusions:

    • Circulating immune complexes (CIC) play a significant role in the rapid clearance of transfused platelets from circulation.
    • Elevated CIC levels adversely affect the therapeutic benefit of platelet transfusions in acute leukemia patients.
    • Monitoring CIC levels may be crucial for optimizing platelet transfusion strategies in leukemia treatment.